Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI chatbot may sharpen nurses' cancer care decisions

NCT ID NCT07806396

Knowledge-focused Sponsor: Sakarya University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 08, 2026 · Last updated Sep 09, 2026 · Updated 1 time

Summary

This trial tests whether an AI-supported chatbot can boost nursing students' knowledge of gynecologic cancers and their clinical decision-making skills. Third-year nursing students who have completed their obstetrics and gynecology course will be randomly assigned to either use the chatbot or receive conventional education. Researchers will compare changes in knowledge test scores and self-reported decision-making abilities between the two groups before and after the training.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
AI-supported educational chatbot platform (OSCE Coach Platform)
What this could lead to
If effective, this approach could offer a new way to train nursing students, potentially improving their knowledge and decision-making in gynecologic cancer care.
What could go wrong
The trial is small and measures self-reported skills, not real patient outcomes. The chatbot's benefit over conventional teaching may be limited or not generalizable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

110 people

The number who actually took part.

Started

Jun 2026

Finished

Sep 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Enrolled as third-year undergraduate nursing students. Successfully completed the Obstetrics and Gynecology Nursing (Women's Health and Diseases Nursing) course. Volunteered to participate and provided digital informed consent. Exclusion Criteria: \-

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chatbot-based training are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

female reproductive organ cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chatbot-based training Clinical decision-making Gynecologic cancers Nursing education

Contacts and locations

Locations

  • Sakarya University

    Sakarya, Turkey, 54050, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.